Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Stentys SA Announces Results of Clinical Stuy Comparing Self-Apposing Stents with Conventional Stents


Thursday, 3 Jan 2013 12:00pm EST 

Stentys SA announced that results from the foundational APPOSITION II clinical trial were published in the December issue of the American College of Cardiology’s journal, JACC Cardiovascular Interventions. The study, conducted between December 2009 and June 2010, compared the accurate implantation of the STENTYS Self-Apposing stent against a conventional balloon-expandable stent in 80 patients treated for a severe form of heart attack, called ST-segment elevation myocardial infarction (STEMI). Placement accuracy was measured by high-definition imaging inside the artery (OCT) three days after treatment. The study results showed that 28% of the patients treated with conventional stents had a gap between the stent mesh and the artery wall (also called malapposition) whereas 0% of the patients with STENTYS stents had malapposed stents. This result was statistically significant (p<0.001). 

Company Quote

6.42
-0.11 -1.68%
19 Sep 2014